High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: A meta-analysis

Atherosclerosis

Volumn 240, Issue 1, 2015, Pages 197-204

  D'Ascenzo, Fabrizio ^a,i   Cerrato, Enrico ^a,i   Calcagno, Andrea ^d   Grossomarra, Walter ^a   Ballocca, Flavia ^a   Omedè, Pierluigi ^a   Montefusco, Antonio ^a   Veglia, Simona ^b   Barbero, Umberto ^a   Gili, Sebastiano ^a   Cannillo, Margherita ^a   Pianelli, Martina ^a   Mistretta, Elisa ^a   Raviola, Alessio ^a   Salera, Davide ^a   Garabello, Domenica ^b   Mancone, Massimo ^f   Estrada, Vicente ^g   Escaned, Javier ^g,i   De Marie, Daniela ^h   Abbate, Antonio ^c   Bonora, Stefano ^d   Zoccai, Giuseppe Biondi ^e,i   Moretti, Claudio ^a,i   Gaita, Fiorenzo ^a   more..

^a UNIVERSITY OF TURIN   (Italy)

^b Division of Radiology   (Italy)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d AMEDEO DI SAVOIA HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f POLICLINICO UMBERTO I   (Italy)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h Maria Vittoria Hospital   (Italy)

ⁱ Cardiogrouporg Collaborative Group   (Italy)

Author keywords

CCT; HAART; HIV; Non calcific plaques

Indexed keywords

CD4 ANTIGEN; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; ASYMPTOMATIC INFECTION; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; COMPUTED CORONARY TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ANGIOCARDIOGRAPHY; ASYMPTOMATIC DISEASE; CHI SQUARE DISTRIBUTION; CORONARY BLOOD VESSEL; CORONARY STENOSIS; HIV INFECTIONS; INCIDENCE; ODDS RATIO; PREDICTIVE VALUE; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; VASCULAR CALCIFICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASYMPTOMATIC DISEASES; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; HIV INFECTIONS; HUMANS; INCIDENCE; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; VASCULAR CALCIFICATION;

EID: 84925115259     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.03.019     Document Type: Article

References (42)

1. Burgess M.J., Kasten M.J. Human immunodeficiency virus: what primary care clinicians need to know. Mayo Clin. Proc. 2013 Dec, 88(12):1468-1474.
2. Dabhadkar K.C. Bellam N Polypill strategy for primary prevention of cardiovascular disorders. Drugs Today (Barc) 2013 May, 49(5):317-324.
3. Burkholder G.A., Tamhane A.R., Salinas J.L., Mugavero M.J., Raper J.L., Westfall A.O., et al. Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Clin. Infect. Dis. 2012 Dec, 55(11):1550-1557.
4. Cerrato E., D'Ascenzo F., Biondi-Zoccai G., Calcagno A., Frea S., Grosso Marra W., et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur. Heart J. 2013 May, 34(19):1432-1436.
5. D'Ascenzo F., Cerrato E., Appleton D., Moretti C., Calcagno A., Abouzaki N., Vetrovec G., Lhermusier T., Carrie D., Das Neves B., Escaned J., Cassese S., Kastrati A., Chinaglia A., Belli R., Capodanno D., Tamburino C., Santilli F., Parodi G., Vachiat A., Manga P., Vignali L., Mancone M., Sardella G., Fedele F., DiNicolantonio J.J., Omedè P., Bonora S., Gaita F., Abbate A., Zoccai G.B. Percutaneous coronary intervention and surgical revascularization in HIV Database (PHD) Study investigators Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. Thromb. Res. 2014 Sep, 134(3):558-564. Epub 2014 Jun 2. 10.1016/j.thromres.2014.05.037.
6. D'Ascenzo F., Cerrato E., Biondi-Zoccai G., Moretti C., Omedè P., Sciuto F., et al. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur. Heart J. 2012 Apr, 33(7):875-880.
7. Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N.Engl. J. Med. 2008, 358:1336-1345.
8. D'Ascenzo F., Agostoni P., Abbate A., Castagno D., Lipinski M.J., Vetrovec G.W., et al. Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. Atherosclerosis 2013 Jan, 226(1):178-185.
9. Stone G.W., Maehara A., Lansky A.J., de Bruyne B., Cristea E., Mintz G.S., et al. PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N.Engl. J. Med. 2011 Jan 20, 364(3):226-235.
10. Ellims A.H., Wong G., Weir J.M., Lew P., Meikle P.J., Taylor A.J. Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease. Eur. Heart J. Cardiovasc Imaging 2014, 15(8):908-916.
11. D'Ascenzo F., Cerrato E., Biondi-Zoccai G., Omedè P., Sciuto F., Presutti D.G., et al. Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. Eur. Heart J. Cardiovasc Imaging 2013 Aug, 14(8):782-789.
12. Kamperidis V., de Graaf M.A., Broersen A., Ahmed W., Sianos G., Delgado V., et al. Prognostic value of aortic and mitral valve calcium detected by contrast cardiac computed tomography angiography in patients with suspicion of coronary artery disease. Am. J. Cardiol. 2014 Mar 1, 113(5):772-778.
13. Hsue P.Y., Lo J.C., Franklin A., Bolger A.F., Martin J.N., Deeks S.G., Waters D.D. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004, 109:1603-1608.
14. Currier J.S., Kendall M.A., Henry W.K., Alston-Smith B., Torriani F.J., Tebas P., Li Y., et al. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 2007, 21:1137-1145.
15. Grunfeld C., Delaney J.A., Wanke C., Currier J.S., Scherzer R., Biggs M.L., et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009, 23:1841-1849.
16. Moher D., Liberati A., Tetzlaff J., Altman D.G. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009 Jul 21, 339:b2535. 10.1136/bmj.b2535.
17. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of Meta-analyses. Lancet 1999 Nov 27, 354(9193):1896-1900.
18. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational Studies in epidemiology (MOOSE) group. JAMA 2000 Apr 19, 283(15):2008-2012.
19. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
20. Post W.S., Budoff M., Kingsley L., Palella F.J., Witt M.D., Li X., et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann. Intern Med. 2014 Apr 1, 160(7):458-467. 10.7326/M13-1754.
21. D'Abramo A., D'Agostino C., Oliva A., Iannetta M., D'Ettorre G., Vullo F., et al. Early atherosclerosis in HIV infected subjects on suppressive antiretroviral treatment: role of osteoprotegerin. ISRN AIDS 2013 Dec, 5:737083.
22. Zanni M.V., Abbara S., Lo J., Wai B., Hark D., Marmarelis E., Grinspoon S.K. Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men. AIDS 2013 May 15, 27(8):1263-1272. AIDS. 2012 Nov 28;26(18):2409-12.
23. Pereyra F., Lo J., Triant V.A., Wei J., Buzon M.J., Fitch K.V., et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS 2012 Nov 28, 26(18):2409-2412.
24. Hwang J.J., Wei J., Abbara S., Grinspoon S.K., Lo J. Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients. J.Acquir Immune Defic. Syndr. 2012 Nov 1, 61(3):359-363.
25. Duarte H., Matta J.R., Muldoon N., Masur H., Hadigan C., Gharib A.M. Non-calcified coronary plaque volume inversely related to CD4(+) T-cell count in HIV infection. Antivir. Ther. 2012, 17(4):763-767.
26. Burdo T.H., Lo J., Abbara S., Wei J., DeLelys M.E., Preffer F., et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J.Infect. Dis. 2011 Oct 15, 204(8):1227-1236.
27. Fitch K.V., Lo J., Abbara S., Ghoshhajra B., Shturman L., Soni A., et al. Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters. J.Acquir Immune Defic. Syndr. 2010 Dec, 55(4):495-499.
28. Lo J., Abbara S., Shturman L., Soni A., Wei J., Rocha-Filho J.A., Nasir K., et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010 Jan 16, 24(2):243-253.
29. Stone G.W., Maehara A., Lansky A.J., de Bruyne B., Cristea E., Mintz G.S., et al. Aprospective natural-history study of coronary atherosclerosis. N.Engl. J. Med. 2011 Jan 20, 364(3):226-235.
30. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J.Am. Coll. Cardiol. 2006, 47:C13-C18.
31. Hausleiter J., Meyer T., Hadamitzky M., Kastrati A., Martinoff S., Schömig A. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J.Am. Coll. Cardiol. 2006 Jul 18, 48(2):312-318.
32. Park G.M., Lee S.W., Cho Y.R., Kim C.J., Cho J.S., Park M.W., Her S.H., Ahn J.M., Lee J.Y., Park D.W., Kang S.J., Kim Y.H., Lee C.W., Koh E.H., Lee W.J., Kim M.S., Lee K.U., Kang J.W., Lim T.H., Park S.W., Park S.J., Park J.Y. Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus. Am. J. Cardiol. 2014 Mar 1, 113(5):765-771.
33. Meng Q., Lima J.A., Lai H., Vlahov D., Celentano D.D., Strathdee S.A., Nelson K.E., Wu K.C., Chen S., Tong W., Lai S. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am. Heart J. 2002 Oct, 144(4):642-648.
34. Talwani R., Falusi O.M., Mendes de Leon C.F., Nerad J.L., Rich S., Proia L.A., Sha B.E., Smith K.Y., Kessler H.A. Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. J.Acquir Immune Defic. Syndr. 2002 Jun 1, 30(2):191-195.
35. Sacre K., Hunt P.W., Hsue P.Y., Maidji E., Martin J.N., Deeks S.G., et al. Arole for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis. AIDS 2012 Apr 24, 26(7):805-814.
36. Steele A.K., Lee E.J., Manuzak J.A., Dillon S.M., Beckham J.D., et al. Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Exvivo. Retrovirology 2014 Feb 4, 11:14.
37. Zanni M.V., Kelesidis T., Fitzgerald M.L., Lo J., Abbara S., Wai B., et al. HDL redox activity is increased in HIV-infected men in association with macrophage activation and noncalcified coronary atherosclerotic plaque. Antivir. Ther. 2014 Feb 17, 19(8):805-811.
38. Kaplan R.C., Kingsley L.A., Gange S.J., Benning L., Jacobson L.P. Lazar J,Anastos K, Tien PC, Sharrett AR, Hodis HN. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008 Aug 20, 22(13):1615-1624.
39. Calvo-Sánchez M., Perelló R., Pérez I., et al. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. Hiv. Med. 2013, 14:40-48.
40. Hulbert A., Hooker C.M., Keruly J.C., Brown T., Horton K., Fishman E., et al. Prospective CT screening for lung Cancer in a high-risk Population: HIV-positive smokers. J.Thorac. Oncol. 2014 Jun, 9(6):752-759.
41. Detrano R1, Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N.Engl. J. Med. 2008, 358:1336-1345.
42. Burkholder G.A., Tamhane A.R., Salinas J.L., Mugavero M.J., Raper J.L., Westfall A.O., et al. Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Clin. Infect. Dis. 2012 Dec, 55(11):1550-1557.